Autolus Therapeutics plc (FRA:6A3A)
Germany
· Delayed Price · Currency is EUR 1.330
+0.080 (6.40%)
At close: Dec 5, 2025
Autolus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -224.8 | -220.66 | -208.38 | -148.84 | -142.1 | -142.09 | Upgrade
|
| Depreciation & Amortization | 9.26 | 7.72 | 6.57 | 7.36 | 8.37 | 5.57 | Upgrade
|
| Other Amortization | - | - | - | 0.07 | 0.09 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0.22 | 3.79 | 0.52 | 0.67 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.41 | 0.38 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.04 | -1.25 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 17.23 | 15.47 | 11.2 | 12.01 | 9.94 | 20.11 | Upgrade
|
| Other Operating Activities | 8.13 | 15.47 | 40.56 | 16.04 | 4.76 | -2.84 | Upgrade
|
| Change in Accounts Receivable | -32.73 | - | - | - | - | - | Upgrade
|
| Change in Inventory | -34.37 | -4.23 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 9.15 | 1.59 | -0.51 | 0.02 | -1.82 | 1.44 | Upgrade
|
| Change in Other Net Operating Assets | -5.62 | -21.02 | 0.8 | 0.51 | 2.23 | -0.03 | Upgrade
|
| Operating Cash Flow | -254.18 | -206.27 | -145.59 | -112.31 | -117.86 | -117.76 | Upgrade
|
| Capital Expenditures | -31.04 | -22.08 | -10.99 | -10.84 | -8.86 | -14.68 | Upgrade
|
| Sale (Purchase) of Intangibles | -20.83 | -12.74 | - | - | - | - | Upgrade
|
| Investment in Securities | -259.8 | -359.73 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -311.67 | -394.55 | -10.99 | -10.84 | -8.86 | -14.68 | Upgrade
|
| Issuance of Common Stock | 0.01 | 550.58 | 0.03 | 163.97 | 246.03 | 80.21 | Upgrade
|
| Other Financing Activities | 27.46 | 38.98 | -0.91 | 59.64 | 38.04 | -5.8 | Upgrade
|
| Financing Cash Flow | 27.47 | 589.55 | -0.88 | 223.61 | 284.06 | 74.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | -32.53 | -0.26 | 15.03 | -28.38 | -0.75 | 0.68 | Upgrade
|
| Net Cash Flow | -570.91 | -11.53 | -142.43 | 72.09 | 156.59 | -57.35 | Upgrade
|
| Free Cash Flow | -285.22 | -228.35 | -156.57 | -123.15 | -126.72 | -132.44 | Upgrade
|
| Free Cash Flow Margin | -557.85% | -2256.38% | -9221.02% | -1936.31% | -5438.54% | -7722.39% | Upgrade
|
| Free Cash Flow Per Share | -1.07 | -0.90 | -0.90 | -1.30 | -1.76 | -2.57 | Upgrade
|
| Cash Income Tax Paid | 2.67 | 2.39 | 0.55 | 0.47 | 0.36 | -19.78 | Upgrade
|
| Levered Free Cash Flow | -267.75 | -187.04 | -125.13 | -75.76 | -77.76 | -91.51 | Upgrade
|
| Unlevered Free Cash Flow | -260.63 | -181.23 | -96.97 | -70.2 | -77.07 | -91.51 | Upgrade
|
| Change in Working Capital | -55.96 | -23.66 | 0.29 | 0.54 | 0.41 | 1.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.